State Group Insurance Program Coverage for Diagnostic and Supplemental Breast Examinations:
Summary
HB 141 amends Florida’s state group insurance program laws to require coverage for diagnostic breast examinations and supplemental breast examinations without enrollee cost-sharing. The bill defines both terms in statute. A diagnostic breast examination is a medically necessary imaging exam used to evaluate an abnormality seen or suspected during a breast cancer screening, and a supplemental breast examination is a medically necessary imaging exam used to screen for breast cancer in individuals with elevated risk based on personal history, family history, or other risk factors. The bill ties these definitions to the most recent applicable guidelines of the National Comprehensive Cancer Network.
The bill also adds a new prohibition to the state employee health benefits program: if a plan covers these breast examinations, the program may not impose deductibles, copayments, coinsurance, or other enrollee cost-sharing for them. It includes a federal-law safeguard for health savings account-qualified high-deductible health plans, preserving compatibility with Internal Revenue Code requirements by limiting when the no-cost-sharing rule applies. The act is scheduled to take effect on January 1, 2026.
Impact
HB 141 would amend sections 110.123 and 110.12303, Florida Statutes, affecting the state group insurance program and the health benefits offered to state employees. Its practical effect is to make diagnostic and supplemental breast imaging more accessible for covered enrollees by eliminating out-of-pocket costs when those services are covered under the plan, while preserving federal HSA-related rules for qualifying high-deductible plans. The bill primarily affects the Department of Management Services, state employee health plans, insurers or administrators participating in the program, and enrollees who need breast cancer-related imaging.
Sentiment
The available context suggests generally favorable sentiment toward the bill, as reflected by its advancement through the legislative process and the enactment of a companion measure, SB 158, which became Chapter 2025-44. There are no recorded committee transcripts or roll-call votes in the provided material showing opposition or debate, and the bill was ultimately laid on the table in the House after the companion bill passed. Overall, the measure appears to have been treated as a health coverage expansion with broad policy support.
Contention
The main policy issue embedded in the bill is cost-sharing: supporters would favor removing financial barriers to medically necessary breast imaging, while any concern would likely center on the added cost to the state group insurance program and the administrative complexity of aligning coverage with federal HSA rules. Another possible point of discussion is the scope of the new definitions, which rely on NCCN guidelines and include risk-based supplemental screening, potentially affecting how broadly the benefit is applied. No specific objections, amendments, or named opponents appear in the provided record.